المؤلفون: Miller ER; a Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta , Georgia , USA., Lewis P; a Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta , Georgia , USA., Shimabukuro TT; a Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta , Georgia , USA., Su J; a Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta , Georgia , USA., Moro P; a Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta , Georgia , USA., Woo EJ; b Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration , Silver Spring , Maryland , USA., Jankosky C; b Office of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration , Silver Spring , Maryland , USA., Cano M; a Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta , Georgia , USA.

المصدر: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2018; Vol. 14 (8), pp. 1963-1969. Date of Electronic Publication: 2018 May 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Adverse Drug Reaction Reporting Systems/*statistics & numerical data , Herpes Zoster/*prevention & control , Herpes Zoster Vaccine/*adverse effects , Herpesvirus 3, Human/*pathogenicity , Product Surveillance, Postmarketing/*statistics & numerical data, Adult ; Age Factors ; Aged ; Aged, 80 and over ; Anaphylaxis/epidemiology ; Anaphylaxis/etiology ; Cause of Death ; Drug Approval ; Drug Eruptions/epidemiology ; Drug Eruptions/etiology ; Female ; Herpes Zoster/epidemiology ; Herpes Zoster/virology ; Herpesvirus 3, Human/immunology ; Humans ; Injection Site Reaction/epidemiology ; Injection Site Reaction/etiology ; Male ; Middle Aged ; Pregnancy ; United States/epidemiology ; Vaccination/adverse effects ; Vaccination/legislation & jurisprudence ; Vaccines, Attenuated/adverse effects

المؤلفون: Woo EJ; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States. Electronic address: jane.woo@fda.hhs.gov., Moro PL; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Cano M; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States., Jankosky C; Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.

المصدر: Vaccine [Vaccine] 2017 Oct 09; Vol. 35 (42), pp. 5618-5621. Date of Electronic Publication: 2017 Sep 05.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Adverse Drug Reaction Reporting Systems/*statistics & numerical data , Drug-Related Side Effects and Adverse Reactions/*immunology , Influenza Vaccines/*adverse effects , Influenza Vaccines/*immunology , Influenza, Human/*immunology , Product Surveillance, Postmarketing/*statistics & numerical data, Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Female ; Humans ; Hypersensitivity, Immediate/chemically induced ; Hypersensitivity, Immediate/immunology ; Male ; Middle Aged ; United States ; United States Food and Drug Administration ; Vaccination/methods ; Young Adult

المؤلفون: Haber P; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) , 1600 Clifton Rd NE, Atlanta GA 30329, United States. Electronic address: PHaber@cdc.gov., Moro PL; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) , 1600 Clifton Rd NE, Atlanta GA 30329, United States., Lewis P; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) , 1600 Clifton Rd NE, Atlanta GA 30329, United States., Woo EJ; Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Biostatistics and Epidemiology, Silver Spring, MD, United States., Jankosky C; Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Biostatistics and Epidemiology, Silver Spring, MD, United States., Cano M; Immunization Safety Office, Division of Healthcare Quality Promotion, National Center Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC) , 1600 Clifton Rd NE, Atlanta GA 30329, United States.

المصدر: Vaccine [Vaccine] 2016 May 11; Vol. 34 (22), pp. 2507-12. Date of Electronic Publication: 2016 Mar 23.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

مواضيع طبية MeSH: Product Surveillance, Postmarketing*, Influenza Vaccines/*adverse effects , Influenza, Human/*prevention & control, Adolescent ; Anaphylaxis/etiology ; Bayes Theorem ; Child ; Child, Preschool ; Data Mining ; Female ; Fever/etiology ; Guillain-Barre Syndrome/etiology ; Humans ; Infant ; Influenza Vaccines/administration & dosage ; Influenza, Human/virology ; Licensure ; Male ; Seizures/etiology ; United States ; Vaccines, Inactivated/administration & dosage ; Vaccines, Inactivated/adverse effects